From GlobeNewswire: 2025-06-19 09:45:00

The Hyaluronic Acid Market was valued at USD 10.90 billion in 2024 and is projected to reach USD 18.53 billion by 2032, with a CAGR of 6.92% over the forecast period. Its growth is driven by its diverse applications in dermatology, orthopedics, ophthalmology, and drug delivery systems, as well as increasing consumer demand for non-invasive cosmetic procedures and anti-aging products.

In the United States, the hyaluronic acid market was valued at USD 3.95 billion in 2023 and is expected to reach USD 6.56 billion by 2032, supported by the presence of aesthetic service providers, technological advancements, and growing preference for FDA-approved injectable treatments. The U.S. market is also benefiting from the increased use of HA in ophthalmic and orthopedic treatments.

The global market for hyaluronic acid is segmented by product, application, grade, and end-use. In terms of product, multiple injection doses dominated the market share in 2024, while dermal fillers were the largest application segment, with the ophthalmic segment projected to experience rapid growth. Pharmaceutical-grade HA led the market in 2023, and North America was the dominant region due to enhanced healthcare infrastructure and aesthetic awareness.

Recent developments in the industry include Allergan Aesthetics showcasing innovation in medical dermatology and aesthetics, and Anika Therapeutics introducing Hyaff, a HA-based solid product platform for joint and tissue repair. The APAC region is experiencing significant growth in the market due to rising disposable income, aging population, and the popularity of cosmetic surgeries in countries like Japan, South Korea, and China.



Read more at GlobeNewswire: Hyaluronic Acid Market Projected to Reach USD 18.53 Billion